Increasing Adoption of Point-of-Care (PoC) Urine Diagnostic Tests & Technological Advancements in Urine Analyzers Catapults the Billion Dollar Global Urinalysis Market

The Global Urinalysis Market is expected to clock US$ 7 billion by 2031 owing to increasing adoption of point-of-care (PoC) urine diagnostic tests, rising prevalence of liver diseases, kidney diseases, diabetes & urinary tract infections (UTIs) and technological advancements in urine analyzers.

Clairvoyance Research conducted an in-depth market analysis study of the global urinalysis market. The study comprehensively analyzes the market from different perspectives and provides granular insights on hot revenue pockets, headwinds & tailwinds impacting the market, quantitative (market size & forecasts) and qualitative analysis on different segments, key strategies and competitive landscape.

Access ‘Sample Pages’ of the Report

Key Market Trends

The urinalysis analysis is expected to fueled by technological advancements and heightended demand of point-of-care (PoC) urine diagnostic tests. There is high demand for technologically advanced urinalysis instruments that can provide accurate results in a timely manner in the laboratory setting. Many mid- and high-volume laboratories are automating their urinalysis testing by using integrated platforms that can perform initial screening and required confirmatory testing with microscopy. There has been continuous demand from laboratories for scalable urinalysis solutions to cater to the growing needs within their network.

The global urinalysis market has been analyzed from four different perspectives – Test Type, Product Type, Application, End User and Region.

Key Takeaways – Application Perspective

The global urinalysis market has been segmented majorly into two distinct categories depending on application, viz. pregnancy tests and disease diagnostics. The disease diagnostics segment accounted for the largest share in the market. Urinalysis is a reliable technique for the diagnosis of various urological conditions, namely urinary tract infection (UTI), calculi and malignancy, among others. Urinalysis tests can be performed among cases of hematuria, as routine check-up for both children & adults, for individuals with symptoms of urinary tract infection (UTI) and candidates with high risks of renal diseases.

Key Takeaways – Regional Perspective

The global urinalysis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America dominates the urinalysis market, followed by Asia Pacific. The large share of North America in the global market can be largely attributed to its well-developed healthcare facilities, increasing adoption of highly advanced urinalysis analyzers in hospital settings, increasing incidence of chronic kidney diseases & urinary tract infections and presence of prominent players in the region.

Snapshot - Competitive Landscape

The market is marked by presence of prominent players such as F. Hoffmann-La Roche Ltd, Sysmex, Beckman Coulter, Inc., ARKRAY USA, Inc., Siemens Healthcare GmbH, Abbott, Bio-Rad Laboratories, Inc., ACON Laboratories, Inc., URIT Medical Electronic Co., Ltd., 77 Elektronika Kft. Other players operating in the market are Cardinal Health, Quidel Corporation, among others.

For deep-rooted insights, please explore the Report

NEED MORE?

• Talk to us about your requirements and get a customized report
• Get more details about the content of report
• Request a Free ‘Sample Pages’ of the report